Mohit Kumar | Nanotechnology | Best Researcher Award

Dr. Mohit Kumar | Nanotechnology | Best Researcher Award

King Mongkut’s University of Technology North Bangkok | Thailand

Dr. Mohit Kumar, currently serving as a Research Scientist – Specialist II at the Academic Enhancement Department, King Mongkut’s University of Technology North Bangkok, is a highly accomplished researcher in the field of fiber-reinforced polymer composites, sustainable materials, and additive manufacturing. With a strong academic foundation including a Ph.D. in Mechanical Engineering from Thapar Institute of Engineering and Technology, his research has extensively contributed to the understanding and development of advanced composite joints and biocomposites. Dr. Kumar has authored 23 peer-reviewed documents, which have garnered 165 citations across 113 different sources, reflecting the growing influence and relevance of his work in the scientific community. His h-index of 8 highlights a consistent record of impactful publications. In addition to research, he has actively contributed to academia as a teacher, reviewer for reputed journals, session chair, invited speaker, and editor of several books with publishers such as Springer and Elsevier. He has also been recognized with awards like the Best Researcher Award and Best Teacher Award. His work spans experimental, computational, and sustainable aspects of composite materials, supported by practical expertise in advanced testing instruments and modeling tools, positioning him as a key contributor in the field of materials engineering.

Profiles: Scopus | Orcid

Featured Publications

  • Kumar, M., Vashishtha, G., Dhiman, B., & Chauhan, S. (2025). Bearing response prediction in hydrothermal aged carbon fiber reinforced epoxy composite joints using machine learning techniques. Mechanics of Advanced Composite Structures,  329–338.

  • Kumar, M. (n.d.). Sensitization studies on low cycle fatigue and cryogenic impact behavior of AISI 304 SS weldments. Conference Paper.

Assist. Prof. Dr. Manvi Singh | Pharmacology | Excellence in Innovation Award

Assist. Prof. Dr. Manvi Singh | Pharmacology | Excellence in Innovation Award

Assist. Prof. Dr Manvi Singh | SGT College of Pharmacy | India

Assist. Prof. Dr. Manvi Singh, M. Pharm., Ph.D. in Pharmaceutics, serves as an Assistant Professor in Pharmaceutics at SGT College of Pharmacy, where she also coordinates NAAC Criteria 3, contributes to the Research Committee, and manages Industrial-Academia relations. With a strong background in formulation and development, pharmaceutical characterization, nanotechnology, bioavailability, and pharmacokinetics, she has guided 2 doctoral, 10 postgraduate, and 20 undergraduate students. Dr. Singh has an h-index of 7, with 141 citations across 136 documents, reflecting her impactful contributions in drug delivery systems and nanotherapeutics. Her academic journey includes a Ph.D. exploring nanotherapeutic interventions for biofilm disruption at Jamia Hamdard and Jawaharlal Nehru University, and an M. Pharm. focusing on polymer-based microbial formulations. She has authored several book chapters on advanced drug delivery, wound management, and nanotechnology applications in pharmaceutics, and holds a granted utility patent on antibiotic nanofibers for biofilm inhibition. Her professional experience spans research fellowships, internships at Hilleman Laboratories-MSD Wellcome Trust, and INMAS-DRDO, and roles as a social media analyst at IMS Health. Dr. Singh has presented her doctoral research internationally, including at Oxford University, London, supported by an ICMR travel grant. She actively reviews for national and international journals and is a life member of the Indian Pharmacy Graduate Association and Indian Pharmaceutical Association. Her technical expertise encompasses formulation development, PK/PD studies, analytical techniques (HPLC, AAS), and software tools like Design of Experiments, GraphPad Prism, Origin, and ImageJ. Recognized for excellence in research, she has received awards including the Best Researcher Award at PharmaPick-2024 and the ICMR Senior Research Fellowship. Her work continues to advance pharmaceutical sciences, particularly in nanomedicine-based strategies for biofilm disruption, targeted drug delivery, and wound healing applications.

Profiles: Scopus | Google Scholar

Featured Publications

Darvishi, M., Khan, M. S., Mohapatra, S., Singh, M., Ali, A., Rajabalizadeh, S., et al. (2024). Nanotools as potential approach in effective management of acne. Journal of Drug Delivery Science and Technology, 102, 106380.

Dabas, H., Ali, F., Quadri, K., Dangi, M., Jamil, P., Aslam, M., & Singh, M. (2024). Disrupting bacterial biofilms to combat dental diseases using nanotechnology in oral healthcare. Integrative Biomedical Research, 8(11), 1–14.

Dabas, H., Singh, D., Ali, F., Koley, D., Aslam, M., Bayrakdar, E. T. A., & Singh, M. (2024). Advancements of polymer-based transdermal drug delivery systems in drug bioavailability and patient compliance in United States. Integrative Biomedical Research, 8(2), 1–10.

Singh, M., Singh, K. R., Yadav, A. K., Singh, J., Solanki, P. R., & Singh, R. P. (2024). Nanotechnological aspects for next-generation wound management. Nanotechnological Aspects for Next-Generation Wound Management.

Singh, M., Goel, P., Phagna, M., Badhwar, R., Iqbal, Z., & Mirza, M. A. (2024). Introduction to colonic disorders. In Advanced drug delivery systems for colonic disorders (pp. 1–22).

Singh, M., Dabas, H., Rehman, A., & Solanki, P. R. (2024). Skin tissue engineering based on nanotechnology for wound management. In Nanotechnological aspects for next-generation wound management (pp. 233–244).

Sidi Mohamed Mah | Nephrology | Best Researcher Award

Assist. Prof. Dr. Sidi Mohamed Mah | Nephrology | Best Researcher Award

University de Nouakchott Al Assriya | Mauritania

Dr. Sidi Mohamed MAH, MD, is a highly accomplished Nephrologist and Head of the Nephrology-Hemodialysis Department at the National Hospital Center of Nouakchott, Mauritania, with extensive training in Senegal, France, and the United Kingdom. He has built a distinguished career in clinical nephrology, hemodialysis, peritoneal dialysis, and renal transplantation, complemented by academic contributions that advance renal healthcare in Africa. His doctoral thesis on Autosomal Dominant Polycystic Kidney Disease and subsequent research on dialysis complications underscore his long-standing dedication to patient-centered nephrology. Over the years, Dr. MAH has authored and co-authored impactful peer-reviewed publications, including studies on lupus nephropathy, viral hepatitis in hemodialysis patients, nutritional challenges in dialysis, and the social responsibility of kidney healthcare facilities. His scientific impact is reflected in 6 citations across 2 documents, with an h-index of 1, demonstrating a growing recognition of his contributions in the nephrology community. As both a clinician and researcher, Dr. MAH integrates academic insight with practical expertise, while also leading initiatives that enhance renal care delivery in Mauritania. His ongoing research and leadership in academic medicine position him as a valuable figure in advancing nephrology, fostering international collaborations, and addressing the pressing kidney health challenges in Africa.

Profiles: Scopus 

Featured Publications

Haddiya, I., Ramdani, S., Chtioui, W., Sidi Aly, A., Mah, S. M., Niang, A., et al. (2025). Addressing social responsibility of kidney healthcare facilities in Africa. Frontiers in Health Services, 5, 1523196.

Omar Arturo Hernandez Lopez | Exercise Physiology | Young Scientist Award

Mr. Omar Arturo Hernandez Lopez | Exercise Physiology | Young Scientist Award

 University Hospital Doctor Peset | Spain

Omar Arturo Hernández López, PhD Student at the Service of Endocrinology and Nutrition, FISABIO–University Hospital Doctor Peset / University of Valencia and core member of MITOMETs, brings expertise as a nutritionist (MSc in Sports Nutrition) and a doctoral researcher in Physiology. His work centers on exercise applications to cardiometabolic disease, cancer, ageing, and chronobiology. He coordinates the Exercise Physiology Assessment Unit within the MITOMETs translational group and leads the Physical Activity and Healthy Lifestyle domain for the Valencia pilot of HORUS (Horizon Europe). His portfolio spans study of mitochondrial–endothelial dysfunction in type 2 diabetes, exercise “snack” interventions in metabolic disease, and muscle mass dynamics in weight loss, among others, with funding from national and European sources. He balances rigorous research with international lecturing and strategic project leadership. According to citation databases, he currently holds an h-index of 1, authored 2 documents, and his work has been cited 2 times. Awarded 3rd place in the Spanish National Prize in Sports Medicine, he merges translational science, education, and health promotion through exercise and nutrition across vulnerable and urban settings.

Profiles: Scopus 

Featured Publications

Hernández-López, O. A., Murillo-Ortíz, B., Luna-Marco, C., Cacace, J., Hermo-Argibay, A., Ramírez, V., Guevara-Cruz, M., Pelechá-Salvador, M., Rocha, M., Rovira-Llopis, S., Víctor, V. M., & Torre-Villalvazo, I. (2025). Cardiorespiratory fitness as a key predictor of metabolic, inflammatory, and oxidative stress biomarkers in adults with different physical activity levels. Free Radical Biology and Medicine.

Marzia Traverso | Environmental Science | Sustainable Engineering Leadership Award

Prof. Dr. Marzia Traverso | Environmental Science | Sustainable Engineering Leadership Award

INaB RWTH Aachen University | Germany

Prof. Marzia Traverso has built a distinguished academic profile, supported by significant research contributions and strong bibliometric indicators that demonstrate the global recognition of her work. Her research output includes 143 scholarly documents, which collectively have been cited 4,425 times across 3,221 documents, underscoring both the quality and reach of her publications. These citations reflect the trust and relevance that the academic and professional community place in her work, particularly in the fields of sustainability, civil engineering, and life cycle assessment. Her h-index of 38 is a further testament to the sustained impact of her research, as it indicates that at least 38 of her publications have each been cited 38 times or more. This balance of productivity and influence highlights her ability to produce high-quality research that resonates widely within and beyond her discipline. Such metrics place her among the leading scholars in her field, reinforcing her standing as a respected researcher and academic leader. Combined with her extensive experience in international projects, editorial board memberships, and roles in global sustainability initiatives, these indicators demonstrate her outstanding contributions to advancing knowledge and practice in sustainable engineering and life cycle assessment

Profiles: Scopus | Orcid | Google Scholar | Linkedin

Featured Publications

  • Steidle, C., Ostojic, S., Achterfeldt, S., & Traverso, M. (2025). Small players, big impact? Unveiling practices and challenges of sustainability reporting by German SMEs. Discover Sustainability, 6(780).

  • Knüvener, L. K., Kalverkamp, S., Spillner, J., Wallqvist, J., Khader, W., Ziemann, S., Schuler, J., Mankaa, R. N., Traverso, M., & Grüßer, L. (2025). The thoracic surgery patient’s journey through the hospital – A pilot project on resource consumption and potentials for sustainability. Langenbeck’s Archives of Surgery, 410(1), 200.

  • Ostojic, S., & Traverso, M. (2025). From aluminium to composites: A comparative social life cycle assessment of automotive lightweight components. Journal of Cleaner Production, 523, 146361.

  • Bayram, B., Greiff, K., Gerlich, L., Luthin, A., Hildebrand, L., & Traverso, M. (2025). Environmental and economic implications of selective demolition and advanced recycling of construction waste. Sustainable Production and Consumption.

  • Chabrawi, A. M. R. O., de Andrade, J. M., Ugaya, C. M. L., & Traverso, M. (2025). Towards reliable primary data collection and harmonized set of indicators in S-LCA on the stakeholder worker. International Journal of Life Cycle Assessment.

Olga Golubnitschaja | Medicine | Best Researcher Award

Prof. Dr. Olga Golubnitschaja | Medicine | Best Researcher Award

University Hospital | Friedrich-Wilhelms University of Bonn | Germany

Prof. Dr. Olga Golubnitschaja is an internationally recognized pioneer and world-leading authority in Predictive, Preventive, and Personalised Medicine (3PM), serving as the head of the world’s first 3PM initiative at the University Hospital of Bonn, Germany. She is the President of the European Association for Predictive, Preventive and Personalised Medicine (EPMA, Brussels), connecting experts across 56 countries, and Editor-in-Chief of the EPMA Journal and the SpringerNature book series “Advances in Predictive, Preventive & Personalised Medicine.” With an academic background in biomedicine and decades of leadership in shaping international biomedical research, Prof. Golubnitschaja has made transformative contributions to predictive diagnostics, targeted prevention, personalised treatments, and the integration of artificial intelligence in healthcare. She has authored over 400 peer-reviewed publications, with more than 200 indexed in PubMed, and published extensively in leading journals across disciplines such as oncology, cardiology, neurology, ophthalmology, endocrinology, and molecular medicine. Her cumulative impact is reflected in outstanding scientometric indicators, including an h-index of 46, 208 published documents, and 6,612 citations recorded by Scopus, in addition to a cumulative h-index of 70 on Google Scholar with more than 1,200 citations. These achievements highlight her exceptional influence in advancing innovative medical strategies, patient stratification, and cost-effective healthcare tailored to individual patient needs

Profiles: Scopus | Orcid | Google Scholar | Staff Page

Featured Publications

    • Golubnitschaja, O. (2022). Flavonoids exert potential in the management of hypertensive disorders in pregnancy. Pregnancy Hypertension, 29, 178–180.

    • Golubnitschaja, O. (2022). Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care. EPMA Journal, 13, 267–280.

    • Golubnitschaja, O. (2022). Anti-breast cancer effects of phytochemicals: Primary, secondary, and tertiary care. EPMA Journal, 13, 249–266.

    • Golubnitschaja, O. (2022). Mitochondrial health quality control: Measurements and interpretation in the framework of predictive, preventive, and personalized medicine. EPMA Journal, 13, 281–297.

    • Golubnitschaja, O. (2022). Prostate cancer treatment costs increase more rapidly than for any other cancer—How to reverse the trend? EPMA Journal, 13, 119–122.

Hirokazu Kumazaki | Psychiatry | Best Researcher Award

Prof. Hirokazu Kumazaki | Psychiatry | Best Researcher Award

Nagasaki University | Japan

Professor Hirokazu Kumazaki, M.D., Ph.D., is a distinguished scholar and clinician in neuropsychiatry with a strong academic and clinical background, currently serving as Professor at the Department of Neuropsychiatry, Nagasaki University, School of Medicine. Having earned his Ph.D. in Neuroscience and Neurophysiology from Keio University and he has built an extensive career across leading Japanese medical institutions, including Keio University, University of Fukui, Kanazawa University, the National Center of Neurology and Psychiatry, and Nagasaki University. His clinical expertise spans nearly two decades as a psychiatrist in top hospitals, complemented by leadership roles in research and psychiatry education. Professor Kumazaki has published an impressive body of work, with 82 peer-reviewed international papers, including 32 as first author, one as co-first author, and 44 as co-author, while serving as senior or corresponding author on most of them. His research contributions have been widely recognized, reflected in an h-index of 27, over 2,950 citations, and 86 Scopus-indexed documents. His scholarly focus encompasses preventive interventions for psychiatric disorders, child mental development, and innovative approaches in future psychiatry, making him a leading figure advancing translational research and clinical practice in the field of neuropsychiatry.

Profiles: Scopus | Orcid 

Featured Publications

  • Watanabe, T., Nishida, K., & Kumazaki, H. (2025). Initial study of verbal and nonverbal communication training through the collaborative operation of a humanoid robot for individuals with autism spectrum disorder. Asian Journal of Psychiatry, 82, 104423.

    Yoshimura, Y., Mitani, Y., Ikeda, T., Tanaka, S., Suda, M., Yaoi, K., Hasegawa, C., An, K.-M., Iwasaki, S., Kumazaki, H., et al. (2025). Language and sensory characteristics are reflected in voice-evoked responses in low birth weight children. Pediatric Research. Advance online publication.

    Kumazaki, H., Kanchi, N., Kawata, M., Utsumi, A., Miyashita, T., Sono, T., Lee, A., Taniguchi, D., Tsukazaki, M., Yoshikawa, Y., et al. (2025, October). Social contact support for patients with schizophrenia using a computer graphics avatar in a real city street environment. Asian Journal of Psychiatry, 83, 104668.

    Funayama, M., Hasegawa, Y., Satake, N., Sato, S., Koishikawa, H., Wada, H., Kato, O., Noguchi, M., Kumazaki, H., & Nishimura, K. (2025, August). Closures of psychiatric units in general hospitals undermining progress in psychiatry: A stark contrast between Japan and the world. Psychiatry and Clinical Neurosciences, 79(8).

    Kanchi, N., Yoshikawa, Y., Kawata, M., Utsumi, A., Miyashita, T., Nishikawa, N., Lee, A., Ishiguro, H., Muramatsu, T., & Kumazaki, H. (2025, June 11). Social communication training using a computer graphics avatar in a real city street environment for individuals with autism spectrum disorder. Journal of Autism and Developmental Disorders. Advance online publication.

Francesk Mulita | Surgery | Best Researcher Award

Assist. Prof. Dr. Francesk Mulita | Surgery | Best Researcher Award

University of Patras | Greece

Dr. Francesk Mulita, MD, M.Sc., Ph.D., is a distinguished General Surgeon and medical researcher at the University of Patras and the General University Hospital of Patras, recognized for his significant contributions to surgery, thyroid surgery, and colorectal cancer research. Since earning his medical degree and completing his Master’s thesis, Dr. Mulita has developed an extensive academic and research portfolio with remarkable global impact. He has authored 256 scientific documents, cited 15,887 times across 13,045 scholarly works, reflecting a strong h-index of 38 that highlights both the productivity and influence of his research. With over 402 journal publications in leading SCI and Scopus-indexed platforms, 48 completed and ongoing research projects, 11 published books with ISBNs, and 346 patents either published or in process, his contributions extend across innovation, academic advancement, and clinical practice. His work includes 14 consultancy or industry collaborations, 16 editorial appointments, and an impressive 58 research collaborations worldwide, underscoring his leadership in fostering scientific networks. Furthermore, he has participated in more than 50 multicentric studies, serving as national lead in 19, and has accumulated over 270 PubMed-indexed publications, with more than 200 where he was the corresponding author, demonstrating his sustained excellence in surgical research.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

COVID-19 infection is a significant risk factor for death in patients presenting with acute cholecystitis: a secondary analysis of the ChoCO-W cohort study

Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019

Moderate- to High-grade Blunt Liver and Spleen Injuries Warrant Repeat Imaging to Identify Treatable Complications Results of the Radiographic Evaluation of Delayed Solid Organ Complications EAST Multicenter Trial

Damage control thoracotomy trends, techniques, and outcomes: An EAST multicenter trial

Pain intensity and prognosis of acute pancreatitis in an international, prospective study

 

Denise Cristiana Faro | Cardiology | Best Researcher Award

Dr. Denise Cristiana Faro | Cardiology | Best Researcher Award

University of Catania | Italy

Dr. Denise Cristiana Faro is a dedicated Medical Doctor, Cardiovascular Specialist, and PhD candidate at the University of Catania, whose academic and clinical career centers on advancing the understanding and management of rare cardiomyopathies, with a primary focus on Anderson-Fabry disease and transthyretin cardiac amyloidosis. She has established herself as an emerging leader in translational cardiology by integrating advanced echocardiographic imaging, genetics, and sex-specific approaches into her research, aiming to enhance early diagnosis, risk stratification, and tailored therapeutic strategies. With 22 published documents, 366 citations across 310 documents, and an h-index of 11, her scholarly contributions reflect both depth and growing international recognition. As co-investigator and sub-investigator in numerous multicenter clinical studies and registries, she has collaborated on cutting-edge projects addressing arrhythmic risk, disease biomarkers, wearable device applications, and therapeutic outcomes in Fabry disease and cardiac amyloidosis. Beyond research, Dr. Faro contributes to academic growth through teaching, peer review for high-impact cardiovascular journals, and authorship of book chapters, including Cardioncologia by the Italian Society of Cardiology. Her active memberships in multiple working groups of the European Society of Cardiology and the Italian Society of Cardiology further highlight her role in shaping multidisciplinary and personalized approaches in cardiovascular medicine.

Profiles: Scopus | Orcid

Featured Publications

Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis

Myosin-ATPase inhibitor in real-world patients with obstructive HCM: A report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of Cardiology

Comparison of personality and psychopathology in patients with Fabry disease and patients with end-stage renal disease: a preliminary study

Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects

Assessment of Noninferiority Margins in Cardiovascular Medicine Trials